KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Asset Utilization Ratio (2016 - 2025)

AbbVie (ABBV) has disclosed Asset Utilization Ratio for 13 consecutive years, with 0.46 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 12.91% to 0.46 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.46, a 12.91% increase, with the full-year FY2025 number at 0.45, up 8.87% from a year prior.
  • Asset Utilization Ratio was 0.46 for Q4 2025 at AbbVie, up from 0.44 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.46 in Q4 2025 to a low of 0.33 in Q1 2021.
  • A 5-year average of 0.4 and a median of 0.4 in 2023 define the central range for Asset Utilization Ratio.
  • Biggest YoY gain for Asset Utilization Ratio was 36.78% in 2021; the steepest drop was 11.73% in 2021.
  • AbbVie's Asset Utilization Ratio stood at 0.38 in 2021, then rose by 8.93% to 0.41 in 2022, then fell by 3.26% to 0.4 in 2023, then increased by 0.86% to 0.4 in 2024, then rose by 12.91% to 0.46 in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Asset Utilization Ratio are 0.46 (Q4 2025), 0.44 (Q3 2025), and 0.43 (Q2 2025).